OraSure Technologies Company Profile (NASDAQ:OSUR)

About OraSure Technologies

OraSure Technologies logoOraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Its diagnostic products include tests, such as OraQuick Rapid HIV Test, OraQuick In-Home HIV Test, OraQuick HIV Self-Test, OraQuick HCV Rapid Antibody Test, OraQuick Ebola Rapid Antigen Test, OraSure QuickFlu Rapid Flu A&B Test, OraSure Collection Device, Molecular Collection Systems, Cryosurgical Systems (Skin Lesion Removal Products), Immunoassay Tests and Reagents, Western blot HIV-1 Confirmatory Test and Q.E.D. Saliva Alcohol Test. Its products are sold in the United States and internationally to clinical laboratories and hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: OSUR
  • CUSIP: 68554V10
Key Metrics:
  • Previous Close: $11.15
  • 50 Day Moving Average: $9.46
  • 200 Day Moving Average: $8.50
  • 52-Week Range: $5.57 - $11.48
  • Trailing P/E Ratio: 31.86
  • Foreward P/E Ratio: 46.46
  • P/E Growth: 1.46
  • Market Cap: $622.29M
  • Outstanding Shares: 55,811,000
  • Beta: 1.44
Profitability:
  • Net Margins: 15.38%
  • Return on Equity: 11.64%
  • Return on Assets: 9.99%
Debt:
  • Current Ratio: 6.87%
  • Quick Ratio: 6.32%
Additional Links:
Companies Related to OraSure Technologies:

Analyst Ratings

Consensus Ratings for OraSure Technologies (NASDAQ:OSUR) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $10.38 (6.95% downside)

Analysts' Ratings History for OraSure Technologies (NASDAQ:OSUR)
Show:
DateFirmActionRatingPrice TargetDetails
2/9/2017Canaccord GenuitySet Price TargetBuy$11.00 -> $12.00View Rating Details
2/9/2017Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$11.25View Rating Details
2/9/2017Jefferies Group LLCBoost Price TargetBuy$11.00 -> $12.00View Rating Details
12/20/2016CL KingInitiated CoverageBuy$11.00View Rating Details
9/19/2016BTIG ResearchDowngradeBuy -> Neutral$8.00View Rating Details
8/29/2016StephensUpgradeEqual Weight -> OverweightView Rating Details
7/5/2016MizuhoReiterated RatingOutperform$8.00View Rating Details
5/7/2015JMP SecuritiesDowngradeOutperform -> Market Perform$10.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for OraSure Technologies (NASDAQ:OSUR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017        
2/8/2017Q4 2016$0.06$0.13$34.80 million$35.50 millionViewListenView Earnings Details
11/2/2016Q316$0.07$0.11$31.45 million$32.25 millionViewListenView Earnings Details
8/3/2016Q216$0.05$0.07$31.15 million$31.36 millionViewListenView Earnings Details
5/4/2016Q1$0.02$0.04$28.82 million$29.10 millionViewListenView Earnings Details
2/3/2016Q4$0.03$0.08$29.73 million$32.38 millionViewListenView Earnings Details
11/4/2015Q315($0.01)$0.03$29.58 million$29.90 millionViewListenView Earnings Details
8/5/2015Q215$0.01$0.03$28.95 million$30.34 millionViewListenView Earnings Details
2/4/2015Q414($0.04)($0.05)$28.22 million$28.68 millionViewListenView Earnings Details
11/5/2014Q314($0.05)$0.02$27.20 million$27.85 millionViewListenView Earnings Details
8/6/2014Q214($0.04)$0.04$26.21 million$26.40 millionViewListenView Earnings Details
5/7/2014Q114($0.13)($0.10)$23.28 million$23.50 millionViewListenView Earnings Details
2/5/2014Q413($0.08)$0.11$27.43 million$28.80 millionViewListenView Earnings Details
11/6/2013Q313($0.10)($0.03)$24.21 million$24.70 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.16)($0.10)$23.67 million$24.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.18)($0.18)$20.82 million$21.20 millionViewListenView Earnings Details
2/6/2013Q4 2012($0.14)($0.11)$20.87 million$22.14 millionViewListenView Earnings Details
11/7/2012Q312($0.07)($0.04)$22.26 million$22.10 millionViewN/AView Earnings Details
8/7/2012($0.08)($0.07)ViewN/AView Earnings Details
5/2/2012($0.09)($0.07)ViewN/AView Earnings Details
11/2/2011($0.07)($0.03)ViewN/AView Earnings Details
8/3/2011($0.05)($0.05)ViewN/AView Earnings Details
5/5/2011($0.08)($0.06)ViewN/AView Earnings Details
2/9/2011($0.08)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OraSure Technologies (NASDAQ:OSUR)
Current Year EPS Consensus Estimate: $0.38 EPS
Next Year EPS Consensus Estimate: $0.24 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.02)$0.01($0.01)
Q2 20161$0.03$0.03$0.03
Q3 20161$0.07$0.07$0.07
Q4 20161$0.05$0.05$0.05
Q1 20171$0.17$0.17$0.17
Q2 20171$0.05$0.05$0.05
Q3 20171$0.06$0.06$0.06
Q4 20171$0.06$0.06$0.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OraSure Technologies (NASDAQ:OSUR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OraSure Technologies (NASDAQ:OSUR)
Insider Ownership Percentage: 7.80%
Institutional Ownership Percentage: 79.51%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/16/2017Ronald H SpairCFOSell50,000$11.12$556,000.00View SEC Filing  
2/15/2017Jack E JerrettSVPSell107,288$11.06$1,186,605.28View SEC Filing  
2/15/2017Stephen S Phd TangDirectorSell40,000$11.04$441,600.00View SEC Filing  
2/14/2017Ronald H SpairCFOSell63,720$10.60$675,432.00View SEC Filing  
2/10/2017Mark L KunaSVPSell79,271$10.61$841,065.31View SEC Filing  
1/31/2017Michael CelanoDirectorSell15,000$8.78$131,700.00View SEC Filing  
1/17/2017Ronald H SpairCFOSell3,341$8.71$29,100.11View SEC Filing  
12/15/2016Mark L KunaSVPSell10,000$9.30$93,000.00View SEC Filing  
12/13/2016Douglas A MichelsCEOSell71,466$9.07$648,196.62View SEC Filing  
12/13/2016Mark L KunaSVPSell17,000$9.11$154,870.00View SEC Filing  
12/9/2016Mark L KunaSVPSell3,000$9.03$27,090.00View SEC Filing  
11/23/2016Douglas A MichelsCEOSell30,893$9.02$278,654.86View SEC Filing  
11/23/2016Jack E JerrettSVPSell24,000$9.00$216,000.00View SEC Filing  
9/26/2016Douglas A MichelsCEOSell25,000$8.22$205,500.00View SEC Filing  
8/31/2016Charles W PatrickDirectorSell17,483$8.58$150,004.14View SEC Filing  
8/30/2016Jack E JerrettSVPSell68,686$8.52$585,204.72View SEC Filing  
8/29/2016Charles W PatrickDirectorSell2,250$8.94$20,115.00View SEC Filing  
8/5/2016Charles W PatrickDirectorSell6,575$7.24$47,603.00View SEC Filing  
12/19/2014Ronald H SpairCFOSell75,974$10.01$760,499.74View SEC Filing  
12/9/2014Ronald H SpairCFOSell1,026$10.00$10,260.00View SEC Filing  
12/8/2014Ronald H SpairCFOSell126$10.00$1,260.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OraSure Technologies (NASDAQ:OSUR)
DateHeadline
biz.yahoo.com logoORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi (NASDAQ:OSUR)
biz.yahoo.com - February 24 at 8:10 PM
finance.yahoo.com logoOraSure Technologies Announces Director Retirement (NASDAQ:OSUR)
finance.yahoo.com - February 24 at 8:44 AM
News IconOraSure Technologies, Inc. (NASDAQ:OSUR) – Fast Growth Play with Potential Stock Upside - Winfield Review (NASDAQ:OSUR)
winfieldreview.com - February 23 at 7:09 PM
News IconHow These Medical Instruments Stocks are Faring? -- Tandem Diabetes Care, C. R. Bard, Glaukos, and OraSure Technologies (NASDAQ:OSUR)
www.medindia.net - February 22 at 9:09 AM
zacks.com logoSurging Earnings Estimates Signal Good News for OraSure (OSUR) (NASDAQ:OSUR)
www.zacks.com - February 17 at 8:14 AM
capitalcube.com logoOraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 (NASDAQ:OSUR)
www.capitalcube.com - February 16 at 6:39 PM
capitalcube.com logoOraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 (NASDAQ:OSUR)
www.capitalcube.com - February 16 at 6:39 PM
capitalcube.com logoOraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 (NASDAQ:OSUR)
www.capitalcube.com - February 16 at 6:39 PM
finance.yahoo.com logoZacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies (NASDAQ:OSUR)
finance.yahoo.com - February 16 at 6:39 PM
finance.yahoo.com logoZacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies (NASDAQ:OSUR)
finance.yahoo.com - February 16 at 6:39 PM
finance.yahoo.com logoZacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies (NASDAQ:OSUR)
finance.yahoo.com - February 16 at 6:39 PM
marketexclusive.com logoInsider Trading Activity OraSure Technologies, Inc. (NASDAQ:OSUR) – SVP Sold 79,271 shares of Stock (NASDAQ:OSUR)
marketexclusive.com - February 14 at 10:53 PM
News IconOraSure Technologies, Inc. (NASDAQ:OSUR) Price Target At $11.416 - Transcript Daily (NASDAQ:OSUR)
transcriptdaily.com - February 14 at 2:12 AM
News IconFY2018 EPS Estimates for OraSure Technologies, Inc. (OSUR) Raised by Analyst (NASDAQ:OSUR)
www.topix.com - February 12 at 6:58 PM
istreetwire.com logoStocks on Trader's Radar: OraSure Technologies, Inc. (OSUR), Cypress Semiconductor Corporation (CY), Viavi ... - iStreetWire (NASDAQ:OSUR)
istreetwire.com - February 11 at 1:04 AM
us.rd.yahoo.com logoEdited Transcript of OSUR earnings conference call or presentation 8-Feb-17 10:00pm GMT (NASDAQ:OSUR)
us.rd.yahoo.com - February 10 at 8:02 PM
us.rd.yahoo.com logoOraSure upgraded by Raymond James (NASDAQ:OSUR)
us.rd.yahoo.com - February 10 at 8:02 PM
capitalcube.com logoOraSure Technologies, Inc. :OSUR-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017 (NASDAQ:OSUR)
www.capitalcube.com - February 10 at 8:02 PM
capitalcube.com logoOraSure Technologies, Inc.: Leads amongst peers with strong fundamentals (NASDAQ:OSUR)
www.capitalcube.com - February 10 at 8:02 PM
News IconEquity Focus: Zeroing in on Shares of OraSure Technologies Inc. (OSUR) - Providence Standard (NASDAQ:OSUR)
providencestandard.com - February 9 at 8:14 PM
smarteranalyst.com logoAnalysts Shine Light on 2 Rising Stocks: Sky Solar Holdings Ltd (ADR) (SKYS), OraSure Technologies, Inc. (OSUR) - Smarter Analyst (NASDAQ:OSUR)
www.smarteranalyst.com - February 9 at 8:14 PM
feeds.benzinga.com logo20 Biggest Mid-Day Gainers For Thursday (NASDAQ:OSUR)
feeds.benzinga.com - February 9 at 2:25 PM
fool.com logoWhy OraSure Technologies, Inc. Leaped Higher Today (NASDAQ:OSUR)
www.fool.com - February 9 at 1:57 PM
News IconWhy OraSure Technologies Inc (OSUR) Has Zero-Debt On Its Balance Sheet? (NASDAQ:OSUR)
simplywall.st - February 8 at 8:02 PM
biz.yahoo.com logoORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:OSUR)
us.rd.yahoo.com - February 8 at 8:02 PM
biz.yahoo.com logoQ4 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET (NASDAQ:OSUR)
us.rd.yahoo.com - February 8 at 8:02 PM
us.rd.yahoo.com logoOraSure Announces 2016 Fourth Quarter and Full-Year Financial Results (NASDAQ:OSUR)
us.rd.yahoo.com - February 8 at 8:02 PM
sg.finance.yahoo.com logoOraSure posts 4Q profit (NASDAQ:OSUR)
us.rd.yahoo.com - February 8 at 8:02 PM
biz.yahoo.com logoOraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today (NASDAQ:OSUR)
us.rd.yahoo.com - February 8 at 8:02 PM
biz.yahoo.com logoORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, (NASDAQ:OSUR)
biz.yahoo.com - February 8 at 8:02 PM
finance.yahoo.com logoOraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA (NASDAQ:OSUR)
finance.yahoo.com - February 6 at 9:17 AM
finance.yahoo.com logo6:01 am OraSure settles litigation for patent infringement and breach of contract filed by its subsidiary, DNA Genotek, against Ancestry.comDNA; Ancetry to pay co a settlement fee of $12.5 million (NASDAQ:OSUR)
finance.yahoo.com - February 6 at 9:17 AM
News IconOraSure Technologies, Inc. (NASDAQ:OSUR) Mean Price Target At $11 - Transcript Daily (NASDAQ:OSUR)
transcriptdaily.com - February 5 at 11:54 PM
realistinvestor.com logoOraSure Technologies, Inc. (NASDAQ:OSUR) Mean Rating At $1.75 - RealistInvestor.com (NASDAQ:OSUR)
www.realistinvestor.com - February 5 at 12:07 AM
investornewswire.com logoAnalyst Rating Of OraSure Technologies, Inc. (NASDAQ:OSUR) Revised To 1.75 - Investor Newswire (NASDAQ:OSUR)
www.investornewswire.com - February 3 at 7:54 PM
capitalcube.com logoOraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : February 1, 2017 (NASDAQ:OSUR)
www.capitalcube.com - February 1 at 8:15 PM
News IconChart Indicators in Focus for OraSure Technologies Inc. (OSUR) - Rives Journal (NASDAQ:OSUR)
rivesjournal.com - January 28 at 7:12 PM
realistinvestor.com logoMean Rating Of OraSure Technologies, Inc. (NASDAQ:OSUR) At $1.75 - RealistInvestor.com (NASDAQ:OSUR)
www.realistinvestor.com - January 28 at 7:12 PM
News IconPrice Index Watch on Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - The Tribune (NASDAQ:OSUR)
lakecitytribune.com - January 25 at 11:22 PM
News IconSell-side is Weighing in on OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings - Aiken Advocate (NASDAQ:OSUR)
aikenadvocate.com - January 25 at 11:22 PM
finance.yahoo.com logoResMed (RMD) Beats Earnings and Revenue Estimates in Q2 (NASDAQ:OSUR)
finance.yahoo.com - January 24 at 8:55 AM
capitalcube.com logoOraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : January 23, 2017 (NASDAQ:OSUR)
www.capitalcube.com - January 23 at 7:25 PM
News IconCCI Level Check for OraSure Technologies Inc. (OSUR) - Sherwood Daily (NASDAQ:OSUR)
sherwooddaily.com - January 22 at 11:52 PM
capitalcube.com logoOraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : January 20, 2017 (NASDAQ:OSUR)
www.capitalcube.com - January 20 at 7:55 PM
News IconGearing Up For a Bull Run? Analysts Weigh in on OraSure Technologies, Inc. (NASDAQ:OSUR) - Wall Street Beacon (NASDAQ:OSUR)
wsbeacon.com - January 19 at 11:43 PM
News IconTrading Scope: Indicator Review for OraSure Technologies Inc. (OSUR) - Sherwood Daily (NASDAQ:OSUR)
sherwooddaily.com - January 19 at 11:43 PM
News IconMean Price Target Of OraSure Technologies, Inc. (NASDAQ:OSUR) At $11 - Transcript Daily (NASDAQ:OSUR)
transcriptdaily.com - January 16 at 9:45 AM
News IconStock ABR OraSure Technologies, Inc. (NASDAQ:OSUR) At 1.75 - Stock Observer (NASDAQ:OSUR)
www.thestockobserver.com - January 15 at 12:14 AM
realistinvestor.com logoQuarterly Deferred Tax Assets Of OraSure Technologies, Inc. (NASDAQ:OSUR) At $0.067 Millions - RealistInvestor.com (NASDAQ:OSUR)
www.realistinvestor.com - January 13 at 5:51 AM
News IconWill The Needle Move For OraSure Technologies, Inc. (NASDAQ:OSUR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:OSUR)
wsbeacon.com - January 13 at 5:51 AM

Social

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

Where is OraSure Technologies' stock going? Where will OraSure Technologies' stock price be in 2017?

7 analysts have issued 12 month price targets for OraSure Technologies' shares. Their forecasts range from $8.00 to $12.00. On average, they expect OraSure Technologies' share price to reach $10.38 in the next year.

When will OraSure Technologies announce their earnings?

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.

What are analysts saying about OraSure Technologies stock?

Here are some recent quotes from research analysts about OraSure Technologies stock:

  • According to Zacks Investment Research, "OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians' offices, and workplace sites. " (2/11/2017)

  • BTIG Research analysts commented, "While we do not see any meaningful negatives for OSUR shares and see room for slight appreciation over time, we feel a lot of good news and higher expectations are now built into shares and would prefer a better entry point," analyst Karen Koski wrote in a note.Related Link: How The Zika Virus Spread While Congress With Out On RecessHowever, Koski acknowledged the company's new $18 million HCV test contract, improving operating margins, and a solid balance sheet. But, the analyst prefers to stay on sidelines due to the OraSure's "lumpy sales."Though OSUR has met or exceeded its sales guidance every quarter for the past several years, investors care most about HCV testing and DNAG sales, which can be lumpy," (9/19/2016)

Who owns OraSure Technologies stock?

OraSure Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (7.52%), Dimensional Fund Advisors LP (4.48%), State Street Corp (2.42%), AQR Capital Management LLC (2.13%), Thrivent Financial for Lutherans (0.87%) and Two Sigma Investments LP (0.80%). Company insiders that own OraSure Technologies stock include Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair and Stephen S Phd Tang.

Who sold OraSure Technologies stock? Who is selling OraSure Technologies stock?

OraSure Technologies' stock was sold by a variety of institutional investors in the last quarter, including Bogle Investment Management L P DE, Oxford Asset Management, Two Sigma Investments LP, GSA Capital Partners LLP, Dynamic Technology Lab Private Ltd, GRT Capital Partners L.L.C., Metropolitan Life Insurance Co. NY and Systematic Financial Management LP. Company insiders that have sold OraSure Technologies stock in the last year include Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair and Stephen S Phd Tang.

Who bought OraSure Technologies stock? Who is buying OraSure Technologies stock?

OraSure Technologies' stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Sicart Associates LLC, Russell Investments Group Ltd., Renaissance Technologies LLC, Cadence Capital Management LLC, State Street Corp, Cornercap Investment Counsel Inc. and Allianz Asset Management AG.

How do I buy OraSure Technologies stock?

Shares of OraSure Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of OraSure Technologies stock cost?

One share of OraSure Technologies stock can currently be purchased for approximately $11.15.

OraSure Technologies (NASDAQ:OSUR) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Earnings History Chart

Earnings by Quarter for OraSure Technologies (NASDAQ:OSUR)

Dividend History Chart

Dividend Payments by Quarter for OraSure Technologies (NASDAQ:OSUR)

Last Updated on 2/26/2017 by MarketBeat.com Staff